Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-25-035168

Options or other derivatives

  • Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

George Robert E. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-12 Grant or award : show line 1 in the form Stock Options (right to buy) +150,000 165,336 D
Loading xslF345X05/rdgdoc.xml…